UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
{
"resourceType" : "Bundle",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-MPD-BBDL",
"type" : "collection",
"entry" : [
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD",
"resource" : {
"resourceType" : "MedicinalProductDefinition",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-MPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLMedicinalProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"MedicinalProductDefinition_HydrokortisonOrifarm20mgTablett-SE-PLC-MPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition HydrokortisonOrifarm20mgTablett-SE-PLC-MPD</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-MPD\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-MPD\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-MPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/mpId</code>/SE-100002342-00054330, <code>http://ema.europa.eu/fhir/eurdId</code>/10855</p><p><b>domain</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000004 100000000012}\">Human use</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000005003 200000005004}\">Current</span></p><p><b>combinedPharmaceuticalDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008 100000073664}\">Tablet</span></p><p><b>indication</b>: </p><div><p>Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072051 100000072084}\">Medicinal product subject to medical prescription</span></p><p><b>classification</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000093533 100000096043}\">hydrocortisone</span></p><blockquote><p><b>name</b></p><p><b>productName</b>: Hydrokortison Orifarm 20 mg Tablett</p><blockquote><p><b>part</b></p><p><b>part</b>: Hydrokortison Orifarm</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000003}\">Scientific name part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: 20 mg</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000004}\">Strength part</span></p></blockquote><blockquote><p><b>part</b></p><p><b>part</b>: tablett</p><p><b>type</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/220000000000 220000000005}\">Pharmaceutical dose form part</span></p></blockquote><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 sv}\">Swedish</span></td></tr></table></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/mpId",
"value" : "SE-100002342-00054330"
},
{
"system" : "http://ema.europa.eu/fhir/eurdId",
"value" : "10855"
}
],
"domain" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000004",
"code" : "100000000012",
"display" : "Human use"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000005003",
"code" : "200000005004",
"display" : "Current"
}
]
},
"combinedPharmaceuticalDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004~200000000006~200000000007~200000000008",
"code" : "100000073664",
"display" : "Tablet"
}
]
},
"indication" : "Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.",
"legalStatusOfSupply" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072051",
"code" : "100000072084",
"display" : "Medicinal product subject to medical prescription"
}
]
},
"classification" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000093533",
"code" : "100000096043",
"display" : "hydrocortisone"
}
]
}
],
"name" : [
{
"productName" : "Hydrokortison Orifarm 20 mg Tablett",
"part" : [
{
"part" : "Hydrokortison Orifarm",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000003",
"display" : "Scientific name part"
}
]
}
},
{
"part" : "20 mg",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000004",
"display" : "Strength part"
}
]
}
},
{
"part" : "tablett",
"type" : {
"coding" : [
{
"system" : "http://spor.ema.europa.eu/v1/lists/220000000000",
"code" : "220000000005",
"display" : "Pharmaceutical dose form part"
}
]
}
}
],
"usage" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"language" : {
"coding" : [
{
"system" : "urn:ietf:bcp:47",
"code" : "sv",
"display" : "Swedish"
}
]
}
}
]
}
]
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/RegulatedAuthorization/HydrokortisonOrifarm20mgTablett-SE-PLC-RA",
"resource" : {
"resourceType" : "RegulatedAuthorization",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-RA",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLRegulatedAuthorization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"RegulatedAuthorization_HydrokortisonOrifarm20mgTablett-SE-PLC-RA\"> </a><p class=\"res-header-id\"><b>Generated Narrative: RegulatedAuthorization HydrokortisonOrifarm20mgTablett-SE-PLC-RA</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-RA\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-RA\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-RA-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/fhir/marketingAuthorizationNumber</code>/54330</p><p><b>subject</b>: <a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/220000000060 220000000061}\">Marketing Authorisation</span></p><p><b>region</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></p><p><b>status</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072049 100000072099}\">Valid</span></p><p><b>statusDate</b>: 2017-02-06</p><p><b>holder</b>: <a href=\"Organization-LOC-100005206.html\">Organization Orifarm Generics A/S</a></p><h3>Cases</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Type</b></td><td><b>Date[x]</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://ema.europa.eu/fhir/authorisationDateType dateOfFirstAuthorisation}\">First Authorisation</span></td><td>2017-02-06</td></tr></table></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/fhir/marketingAuthorizationNumber",
"value" : "54330"
}
],
"subject" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
}
],
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/220000000060",
"code" : "220000000061",
"display" : "Marketing Authorisation"
}
]
},
"region" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
}
],
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072049",
"code" : "100000072099",
"display" : "Valid"
}
]
},
"statusDate" : "2017-02-06",
"holder" : {
🔗 "reference" : "Organization/LOC-100005206"
},
"case" : {
"type" : {
"coding" : [
{
"system" : "https://ema.europa.eu/fhir/authorisationDateType",
"code" : "dateOfFirstAuthorisation",
"display" : "First Authorisation"
}
]
},
"dateDateTime" : "2017-02-06"
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/PackagedProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-PPD",
"resource" : {
"resourceType" : "PackagedProductDefinition",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-PPD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLPackagedProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"PackagedProductDefinition_HydrokortisonOrifarm20mgTablett-SE-PLC-PPD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: PackagedProductDefinition HydrokortisonOrifarm20mgTablett-SE-PLC-PPD</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-PPD\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-PPD\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-PPD-en-US\"> </a><p><b>identifier</b>: <code>http://ema.europa.eu/example/pcid</code>/?ngen-9?</p><p><b>packageFor</b>: <a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></p><p><b>containedItemQuantity</b>: 100 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: 200000000014 code200000002152 = '200000002152')</span></p><p><b>description</b>: </p><div><p>Burk, 100 tabletter</p>\n</div><h3>MarketingStatuses</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Status</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000000002 100000000535}\">Kingdom of Sweden</span></td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072052 100000072083}\">Marketed</span></td></tr></table><blockquote><p><b>packaging</b></p><p><b>type</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073346 100000073523}\">Jar</span></p><p><b>quantity</b>: 1</p><p><b>material</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000003199 200000003215}\">High Density PolyEthylene</span></p><blockquote><p><b>containedItem</b></p><h3>Items</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Reference</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"ManufacturedItemDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></td></tr></table><p><b>amount</b>: 100 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: 100000110633~200000000014 code200000002152 = '200000002152')</span></p></blockquote></blockquote></div>"
},
"identifier" : [
{
"system" : "http://ema.europa.eu/example/pcid"
}
],
"packageFor" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
}
],
"containedItemQuantity" : [
{
"value" : 100,
"unit" : "Tablet",
"system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
],
"description" : "Burk, 100 tabletter",
"marketingStatus" : [
{
"country" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000000002",
"code" : "100000000535",
"display" : "Kingdom of Sweden"
}
]
},
"status" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072052",
"code" : "100000072083",
"display" : "Marketed"
}
]
}
}
],
"packaging" : {
"type" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073346",
"code" : "100000073523",
"display" : "Jar"
}
]
},
"quantity" : 1,
"material" : [
{
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000003199",
"code" : "200000003215",
"display" : "High Density PolyEthylene"
}
]
}
],
"containedItem" : [
{
"item" : {
"reference" : {
🔗 "reference" : "ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID"
}
},
"amount" : {
"value" : 100,
"unit" : "Tablet",
"system" : "http://spor.ema.europa.eu/v1/lists/100000110633~200000000014",
"code" : "200000002152"
}
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID",
"resource" : {
"resourceType" : "ManufacturedItemDefinition",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-MID",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLManufacturedItemDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"ManufacturedItemDefinition_HydrokortisonOrifarm20mgTablett-SE-PLC-MID\"> </a><p class=\"res-header-id\"><b>Generated Narrative: ManufacturedItemDefinition HydrokortisonOrifarm20mgTablett-SE-PLC-MID</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-MID\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-MID\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-MID-en-US\"> </a><p><b>status</b>: Active</p><p><b>manufacturedDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}\">Tablet</span></p><p><b>unitOfPresentation</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000014 200000002152}\">Tablet</span></p></div>"
},
"status" : "active",
"manufacturedDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073664",
"display" : "Tablet"
}
]
},
"unitOfPresentation" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152",
"display" : "Tablet"
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/HydrokortisonOrifarm20mgTablett-SE-PLC-ING01",
"resource" : {
"resourceType" : "Ingredient",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-ING01",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_HydrokortisonOrifarm20mgTablett-SE-PLC-ING01\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient HydrokortisonOrifarm20mgTablett-SE-PLC-ING01</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-ING01\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING01\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING01-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></li><li><a href=\"ManufacturedItemDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href=\"AdministrableProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072072}\">Active</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092635}\">Hydrocortisone</span></td></tr></table><blockquote><p><b>strength</b></p><p><b>presentation</b>: 20 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p><blockquote><p><b>referenceStrength</b></p><h3>Substances</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000092635}\">Hydrocortisone</span></td></tr></table><p><b>strength</b>: 20 milligram(s)<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Measurement EMA code100000110655 = 'milligram(s)')</span>/1 Tablet<span style=\"background: LightGoldenRodYellow\"> (Details: Unit of Presentation EMA code200000002152 = 'Tablet')</span></p></blockquote></blockquote></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072072",
"display" : "Active"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000092635",
"display" : "Hydrocortisone"
}
]
}
},
"strength" : [
{
"presentationRatio" : {
"numerator" : {
"value" : 20,
"unit" : "milligram(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
},
"referenceStrength" : [
{
"substance" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000092635",
"display" : "Hydrocortisone"
}
]
}
},
"strengthRatio" : {
"numerator" : {
"value" : 20,
"unit" : "milligram(s)",
"system" : "https://spor.ema.europa.eu/v1/lists/100000110633",
"code" : "100000110655"
},
"denominator" : {
"value" : 1,
"unit" : "Tablet",
"system" : "https://spor.ema.europa.eu/v1/lists/200000000014",
"code" : "200000002152"
}
}
}
]
}
]
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/HydrokortisonOrifarm20mgTablett-SE-PLC-ING02",
"resource" : {
"resourceType" : "Ingredient",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-ING02",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_HydrokortisonOrifarm20mgTablett-SE-PLC-ING02\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient HydrokortisonOrifarm20mgTablett-SE-PLC-ING02</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-ING02\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING02\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING02-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></li><li><a href=\"ManufacturedItemDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href=\"AdministrableProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}\">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000078553}\">Gelatin</span></td></tr></table></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000078553",
"display" : "Gelatin"
}
]
}
}
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/HydrokortisonOrifarm20mgTablett-SE-PLC-ING03",
"resource" : {
"resourceType" : "Ingredient",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-ING03",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_HydrokortisonOrifarm20mgTablett-SE-PLC-ING03\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient HydrokortisonOrifarm20mgTablett-SE-PLC-ING03</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-ING03\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING03\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING03-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></li><li><a href=\"ManufacturedItemDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href=\"AdministrableProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}\">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000129311}\">Granulated lactose monohydrate</span></td></tr></table></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000129311",
"display" : "Granulated lactose monohydrate"
}
]
}
}
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/HydrokortisonOrifarm20mgTablett-SE-PLC-ING04",
"resource" : {
"resourceType" : "Ingredient",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-ING04",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_HydrokortisonOrifarm20mgTablett-SE-PLC-ING04\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient HydrokortisonOrifarm20mgTablett-SE-PLC-ING04</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-ING04\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING04\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING04-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></li><li><a href=\"ManufacturedItemDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href=\"AdministrableProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}\">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000088586}\">Magnesium stearate</span></td></tr></table></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000088586",
"display" : "Magnesium stearate"
}
]
}
}
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/HydrokortisonOrifarm20mgTablett-SE-PLC-ING05",
"resource" : {
"resourceType" : "Ingredient",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-ING05",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_HydrokortisonOrifarm20mgTablett-SE-PLC-ING05\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient HydrokortisonOrifarm20mgTablett-SE-PLC-ING05</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-ING05\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING05\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING05-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></li><li><a href=\"ManufacturedItemDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href=\"AdministrableProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}\">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000079864}\">Potato starch</span></td></tr></table></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000079864",
"display" : "Potato starch"
}
]
}
}
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Ingredient/HydrokortisonOrifarm20mgTablett-SE-PLC-ING06",
"resource" : {
"resourceType" : "Ingredient",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-ING06",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLIngredient"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Ingredient_HydrokortisonOrifarm20mgTablett-SE-PLC-ING06\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Ingredient HydrokortisonOrifarm20mgTablett-SE-PLC-ING06</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-ING06\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING06\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-ING06-en-US\"> </a><p><b>status</b>: Active</p><p><b>for</b>: </p><ul><li><a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></li><li><a href=\"ManufacturedItemDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></li><li><a href=\"AdministrableProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-APD.html\">AdministrableProductDefinition: status = active; administrableDoseForm = Tablet</a></li></ul><p><b>role</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000072050 100000072082}\">Excipient</span></p><blockquote><p><b>substance</b></p><h3>Codes</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Concept</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.azure-api.net/sms/api/v2/SubstanceDefinition 100000078762}\">Talc</span></td></tr></table></blockquote></div>"
},
"status" : "active",
"for" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
},
{
🔗 "reference" : "ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID"
},
{
🔗 "reference" : "AdministrableProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-APD"
}
],
"role" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000072050",
"code" : "100000072082",
"display" : "Excipient"
}
]
},
"substance" : {
"code" : {
"concept" : {
"coding" : [
{
"system" : "https://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
"code" : "100000078762",
"display" : "Talc"
}
]
}
}
}
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/AdministrableProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-APD",
"resource" : {
"resourceType" : "AdministrableProductDefinition",
"id" : "HydrokortisonOrifarm20mgTablett-SE-PLC-APD",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLAdministrableProductDefinition"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"AdministrableProductDefinition_HydrokortisonOrifarm20mgTablett-SE-PLC-APD\"> </a><p class=\"res-header-id\"><b>Generated Narrative: AdministrableProductDefinition HydrokortisonOrifarm20mgTablett-SE-PLC-APD</b></p><a name=\"HydrokortisonOrifarm20mgTablett-SE-PLC-APD\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-APD\"> </a><a name=\"hcHydrokortisonOrifarm20mgTablett-SE-PLC-APD-en-US\"> </a><p><b>status</b>: Active</p><p><b>formOf</b>: <a href=\"MedicinalProductDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MPD.html\">MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00054330,http://ema.europa.eu/fhir/eurdId#10855; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Substitutionsbehandling vid kongenital binjurebarkshyperplasi hos barn. Behandling av binjurebarkinsufficiens hos barn och ungdomar under 18 år. Akut behandling av svår astma, överkänslighetsreaktioner mot läkemedel, serumsjuka, angioneurotiskt ödem och anafylaxi hos vuxna och barn. Hydrokortison Orifarm är avsett för vuxna och barn i åldern 1 månad till 18 år där tablettberedning bedöms lämplig.; legalStatusOfSupply = Medicinal product subject to medical prescription; classification = hydrocortisone</a></p><p><b>administrableDoseForm</b>: <span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/200000000004 100000073664}\">Tablet</span></p><p><b>producedFrom</b>: <a href=\"ManufacturedItemDefinition-HydrokortisonOrifarm20mgTablett-SE-PLC-MID.html\">ManufacturedItemDefinition: status = active; manufacturedDoseForm = Tablet; unitOfPresentation = Tablet</a></p><h3>RouteOfAdministrations</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Code</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{https://spor.ema.europa.eu/v1/lists/100000073345 100000073619}\">Oral use</span></td></tr></table></div>"
},
"status" : "active",
"formOf" : [
{
🔗 "reference" : "MedicinalProductDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MPD"
}
],
"administrableDoseForm" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/200000000004",
"code" : "100000073664",
"display" : "Tablet"
}
]
},
"producedFrom" : [
{
🔗 "reference" : "ManufacturedItemDefinition/HydrokortisonOrifarm20mgTablett-SE-PLC-MID"
}
],
"routeOfAdministration" : [
{
"code" : {
"coding" : [
{
"system" : "https://spor.ema.europa.eu/v1/lists/100000073345",
"code" : "100000073619",
"display" : "Oral use"
}
]
}
}
]
}
},
{
"fullUrl" : "https://hl7-eu.github.io/unicom-ig/branches/mpd-r4b/Organization/LOC-100005206",
"resource" : {
"resourceType" : "Organization",
"id" : "LOC-100005206",
"meta" : {
"profile" : [
🔗 "http://unicom-project.eu/fhir/StructureDefinition/PPLOrganization"
]
},
"text" : {
"status" : "generated",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><a name=\"Organization_LOC-100005206\"> </a><p class=\"res-header-id\"><b>Generated Narrative: Organization LOC-100005206</b></p><a name=\"LOC-100005206\"> </a><a name=\"hcLOC-100005206\"> </a><a name=\"hcLOC-100005206-en-US\"> </a><p><b>identifier</b>: <code>https://spor.ema.europa.eu/v1/locations</code>/LOC-100005206</p><p><b>name</b>: Orifarm Generics A/S</p></div>"
},
"identifier" : [
{
"system" : "https://spor.ema.europa.eu/v1/locations",
"value" : "LOC-100005206"
}
],
"name" : "Orifarm Generics A/S"
}
}
]
}
IG © 2022+ UNICOM. Package hl7.eu.fhir.ufis-swe-unicom#0.1.0 based on FHIR 5.0.0. Generated 2024-06-28
Links: Table of Contents |
QA Report
The UNICOM Innovation Action has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 875299.
